The O’Sullivan research group at University College Dublin is offering 2 fully funded PhD projects to develop novel models and identify potential therapeutic targets to lessen neurodegeneration in severe HSP caused by mutations in the Atlastin gene. Closing date for applications: 31st May 2024. See here for further details.